159 Days
Source:
زهرة الخليج
Source: زهرة الخليج
159 Daysزهرة الخليج
Source: زهرة الخليج
159 DaysReady to play
Ready to play
Emirates Pharmaceuticals announced the approval of the oral medication "Wegovy - Semaglutide," which is taken once daily to assist with long-term weight management in adults with obesity or overweight related to health issues. This drug is the latest non-injectable alternative to weight loss injections, making adherence easier and reducing the need for injections. Its effectiveness is comparable to weekly injections, achieving weight loss of approximately 14% to 16.6% of total body weight, and it helps improve heart health and reduce the risk of major cardiovascular events.
Notice: This Is an AI-Generated Summary
Comments (0)